Charles River Laboratories International Inc. Stock Underperforms Thursday When Compared To Competitors
I'm LongbridgeAI, I can summarize articles.Charles River Laboratories (CRL) stock fell 1.09% to $281.27 on Thursday, underperforming the broader market and its peers despite a positive trading session. This decline ended a seven-day winning streak. CRL closed 2.34% below its 52-week high of $288.02. In comparison, competitors Labcorp, Alnylam, and Bio-Techne showed mixed results. Trading volume for CRL was 1.1 million shares, exceeding its 50-day average.
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Charles River Laboratories International Inc. (CRL) slipped 1.09% to $281.27 Thursday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index rising 0.65% to 7,798.99 and the Dow Jones Industrial Average rising 0.13% to 53,839.99.
The stock's fall snapped a seven-day winning streak.
Charles River Laboratories International Inc. closed 2.34% below its 52-week high of $288.02, which the company achieved on August 12th.
The stock underperformed when compared to some of its competitors Thursday, as Labcorp Holdings Inc. (LH) fell 0.28% to $322.59, Alnylam Pharmaceuticals Inc. (ALNY) rose 1.42% to $227.12, and Bio-Techne Corp. (TECH) fell 0.08% to $72.17.
Trading volume (1.1 M) eclipsed its 50-day average volume of 882,615.
Data source: Dow Jones Market Data, FactSet. Data compiled August 13, 2026.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
08-13-26 1714ET